About Jon Fleetwood
JonFleetwood. com publishes document-driven investigative reporting focused on health policy, biotechnology, biosecurity, and government decision-making. Reporting is grounded in primary sources, peer-reviewed research, government records, and legislative documents, with an emphasis on what official materials explicitly state—and the implications of those statements when examined closely.
About the editor
Jon Fleetwood is the Founder and Editor-in-Chief of JonFleetwood. com.
In June 2024, Fleetwood co-authored a peer-reviewed medical publication in The Gazette of Medical Sciences examining clinical evidence on the safety and efficacy of inhaled budesonide for early and late treatment of COVID-19.